FT Cboe Vest U.S. Equity Moderate Buffer ETF - March GMAR 深 滬
等待開盤 09-13 09:30:00 美东时间
39.9701
-0.020
-0.05%
華盛通- 最 高39.98
- 今 開39.98
- 成交量 6816股
- 最 低 39.95
- 昨 收 39.99
- 總市值 4.44亿
- 52周最高 40.34
- 市盈率 靜 --
- 換手率 0.06%
- 52周最低 34.19
- 委 比 0.00%
- 總股本 1110.00万
- 歷史最高 40.34
- 量 比 0.61
- 振 幅 0.08%
- 歷史最低 29.66
- 每 手 1
- 風險率 1.36%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows
Anavex published data showing blarcamesine prevented amyloid-related brain damage in mice, supporting SIGMAR1 as a target for Alzheimer's prevention.
08-20 19:31
Anavex gains after seeking EU marketing nod for Alzheimer’s drug
Anavex Life Sciences (NASDAQ:AVXL) traded ~10% higher in the premarket after the company said it submitted a marketing authorization application to seek EU approval for its Alzheimer's candidate blarc...
2024-11-26 21:55
FOREWARN Partners With Greater Metropolitan Association of REALTORS
The largest Association in the state of Michigan makes FOREWARN services availa...
2024-05-01 20:00
Anavex Life Sciences Reports New Publication In Scientific Journal Demonstrating The Potential Of ANAVEX 3-71 To Prevent Cognitive Decline In Alzheimer's Disease
ANAVEX®3-71 treatment prevents cognitive impairment, reduces amyloid, and neuroinflammation even after a long drug washout ANAVEX®3-71 halts neurodegeneration and prevents cognitive decline in a transgenic
2023-10-25 20:06
